Drug Profile
Research programme: glucocorticoid receptor agonists - Matrix Therapeutics
Alternative Names: Glucocorticoid receptor agonists - Matrix Therapeutics; Research programme: T25 - Matrix Therapeutics; T25 research programme - Matrix TherapeuticsLatest Information Update: 24 Apr 2007
Price :
$50
*
At a glance
- Originator Matrix Therapeutics
- Class
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 24 Apr 2007 Discontinued - Preclinical for Inflammation in United Kingdom (unspecified route)
- 18 Apr 2001 Preclinical development for Inflammation in United Kingdom (Unknown route)